Stocks and Investing
Stocks and Investing
Wed, August 14, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Emily Bodnar Reiterated (ANAB) at Strong Buy and Held Target at $55 on, Aug 14th, 2024
Emily Bodnar of HC Wainwright & Co., Reiterated "AnaptysBio, Inc." (ANAB) at Strong Buy and Held Target at $55 on, Aug 14th, 2024.
Emily has made no other calls on ANAB in the last 4 months.
There are 3 other peers that have a rating on ANAB. Out of the 3 peers that are also analyzing ANAB, 0 agree with Emily's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Emily
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $75 on, Wednesday, August 7th, 2024
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $34 on, Friday, May 10th, 2024
- David Risinger of "Leerink Partners" Initiated at Buy and Held Target at $47 on, Tuesday, April 16th, 2024
Contributing Sources